Om deze cursus te volgen, moet u een account hebben en ingelogd zijn.


While our armamentarium of so-called high-efficacy drugs grows, each has distinct impacts on the immune system and the underlying disease processes. Mastering these different modes of actions and their consequences is a key when choosing for the most adapted treatment option for an individual patient, as it is for the estimating future risks and for moving from one DMD to another if and when it's necessary.


MS, a complex disease, often requires multidisciplinary interventions. DMDs first act is upon the disease activity, but they can also impact other invisible aspects of the disease such as the Quality of Life (QoL) and societal cost. For this reason, the choice of a DMD goes beyond purely controlling the disease.


Steven Simoens

Health economist

KU Leuven

Bassem Yamout

Professor of Neurology

American University of Beirut
Director, Neurology Institute and MS centre Harley street MC Abu Dhabi UAE

Misschien bent u ook geïnteresseerd in deze cursussen

Prof. Wolf-Henning Boehncke

Psoriatic disease and its comorbidities: impact on treatment/management

Geaccrediteerd voor artsen - 22021990 - 1CP

  • 8 Hoofdstukken
  • 01h 05min

Prof. dr. Johan Flamaing

Herpes zoster: het nieuwe advies van de HGR besproken door prof. dr. Flamaing

Geaccrediteerd voor artsen - 22021577 - 1CP

  • 6 Hoofdstukken
  • 01h 05min

Prof. Patrick Vermersch et Dr. Phyllis Vanwalleghem

New possible treatments for Smouldering MS and Brain Health Importance

Geaccrediteerd voor artsen - 22027767 - 1CP

  • 5 Hoofdstukken
  • 01h 05min

Prof. dr. Willy Poppe et prof. dr. Herman Depypere

Advies aan patiënten over anticonceptie en bespreking van langwerkende omkeerbare anticonceptiemiddelen

Geaccrediteerd voor artsen - 22026599 - 1CP

  • 4 Hoofdstukken
  • 01h 05min